Literature DB >> 29052002

Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.

Maarten M J Wijnenga1, Hendrikus J Dubbink2, Pim J French1, Nathalie E Synhaeve3, Winand N M Dinjens2, Peggy N Atmodimedjo2, Johan M Kros2, Clemens M F Dirven4, Arnaud J P E Vincent4, Martin J van den Bent5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29052002     DOI： 10.1007/s00401-017-1781-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  36 in total

1.  Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.

Authors:  P Darvishi; P P Batchala; J T Patrie; L M Poisson; M-B Lopes; R Jain; C E Fadul; D Schiff; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-23       Impact factor: 3.825

2.  Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.

Authors:  Philip Jonsson; Tejus A Bale; Andrew L Lin; Marc Rosenblum; Ingo K Mellinghoff; Viviane S Tabar; Shahiba Ogilvie; Lauren Schaff; Tzu-I Jonathan Yang; Robert J Young; Barry S Taylor
Journal:  Brain Pathol       Date:  2020-02-12       Impact factor: 6.508

3.  Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features.

Authors:  Patrick J Cimino
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

4.  Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria.

Authors:  C Mircea S Tesileanu; Linda Dirven; Maarten M J Wijnenga; Johan A F Koekkoek; Arnaud J P E Vincent; Hendrikus J Dubbink; Peggy N Atmodimedjo; Johan M Kros; Sjoerd G van Duinen; Marion Smits; Martin J B Taphoorn; Pim J French; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

5.  Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.

Authors:  David Schiff; Martin Van den Bent; Michael A Vogelbaum; Wolfgang Wick; C Ryan Miller; Martin Taphoorn; Whitney Pope; Paul D Brown; Michael Platten; Rakesh Jalali; Terri Armstrong; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

Review 6.  What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas?

Authors:  Roberta Rudà; Francesco Bruno; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2018-07-04       Impact factor: 3.598

7.  IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.

Authors:  Giulia Berzero; Anna Luisa Di Stefano; Susanna Ronchi; Franck Bielle; Chiara Villa; Erell Guillerm; Laurent Capelle; Bertrand Mathon; Alice Laurenge; Marine Giry; Yohann Schmitt; Yannick Marie; Ahmed Idbaih; Khe Hoang-Xuan; Jean-Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

8.  Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

Authors:  Eudocia Q Lee; Michael Weller; Joohee Sul; Stephen J Bagley; Solmaz Sahebjam; Martin van den Bent; Manmeet Ahluwalia; Jian L Campian; Evanthia Galanis; Mark R Gilbert; Matthias Holdhoff; Glenn J Lesser; Frank S Lieberman; Minesh P Mehta; Marta Penas-Prado; Karisa C Schreck; Roy E Strowd; Michael A Vogelbaum; Tobias Walbert; Susan M Chang; L Burt Nabors; Stuart Grossman; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

9.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

10.  Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.

Authors:  María Fernanda Ruiz; María Verónica Gennaro; Laura C Bastone; Alicia R Godoy; Mónica Torruella; Germán R Perez
Journal:  Mol Clin Oncol       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.